The Recall Desk
HighFDA (Food)·F-1430-2017·Announced 2017-02-08

West Coast Laboratories Recalls Xambo and Devagrass Due to DMAA Presence

West Coast Laboratories is recalling Xambo and Devagrass capsules because they may contain 1,3-dimethylamylamine (DMAA). The recall involves 964,240 capsules distributed in Colombia.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a high-risk pathogen or substance (DMAA) without reported illness, fitting the High severity criteria for risk-of-harm products where injury has not yet been reported.

Plain-English summary

West Coast Laboratories is voluntarily recalling Xambo and Devagrass products. The recall is being conducted because there may be the presence of 1,3-dimethylamylamine (DMAA) in the products.

The recall involves 80 boxes of bulk Xambo capsules, with each box containing 12,053 capsules, for a total of 964,240 capsules. The product code is 361215. The distribution pattern indicates these products were distributed in Colombia, South America.

Consumers who have purchased these products should stop using them and contact the recalling firm for further instructions.

The recalled product

Product
Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.
Affected units
964,240

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • 361215

Distribution

Distribution scope not specified by the agency.

Part of a larger recall action

This product is one of 2 recalled by West Coast Laboratories Inc under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Same manufacturer · West Coast Laboratories Inc

See all →